Drug Price Transparency
Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|---|---|---|---|---|
| Imbruvica | 01/01/2024 | Ibrutinib | increased | 972.23 | 100 |
| Imdelltra | 01/01/2024 | Tarlatamab-Dlle | increased | 972.23 | 100 |
| Imdelltra | 01/01/2024 | Tarlatamab-Dlle | increased | 972.23 | 100 |
| Imfinzi | 01/01/2024 | Durvalumab | increased | 972.23 | 100 |
| Imfinzi | 01/01/2024 | Durvalumab | increased | 972.23 | 100 |
| Imitrex* | 01/01/2024 | Sumatriptan Succinate | increased | 972.23 | 100 |
| Imitrex* | 01/01/2024 | Sumatriptan Succinate | increased | 972.23 | 100 |
| Imjudo | 01/01/2024 | Tremelimumab-Actl | increased | 972.23 | 100 |
| Imjudo | 01/01/2024 | Tremelimumab-Actl | increased | 972.23 | 100 |
| Imovax Rabies Vaccine | 01/01/2024 | Rabies Vacc, Human Diploid/PF | increased | 972.23 | 100 |
| Imovax Rabies Vaccine | 01/01/2024 | Rabies Vacc, Human Diploid/PF | increased | 972.23 | 100 |
| Impavido | 01/01/2024 | Miltefosine | increased | 972.23 | 100 |
| Impavido | 01/01/2024 | Miltefosine | increased | 972.23 | 100 |
| Indocin* | 01/01/2024 | Indomethacin | increased | 972.23 | 100 |
| Indocin* | 01/01/2024 | Indomethacin | increased | 972.23 | 100 |
| Indomethacin* | 01/01/2024 | Indomethacin | increased | 972.23 | 100 |
| Inflectra | 01/01/2024 | Infliximab-Dyyb | increased | 972.23 | 100 |
| Inflectra | 01/01/2024 | Infliximab-Dyyb | increased | 972.23 | 100 |
| Infliximab | 01/01/2024 | Infliximab | increased | 972.23 | 100 |
| Infliximab | 01/01/2024 | Infliximab | increased | 972.23 | 100 |
| Ingrezza Initiation Pk(Tardiv) | 01/01/2024 | Valbenazine Tosylate | increased | 972.23 | 100 |
| Ingrezza Initiation Pk(Tardiv) | 01/01/2024 | Valbenazine Tosylate | increased | 972.23 | 100 |
| Ingrezza Sprinkle | 01/01/2024 | Valbenazine Tosylate | increased | 972.23 | 100 |
| Ingrezza Sprinkle | 01/01/2024 | Valbenazine Tosylate | increased | 972.23 | 100 |
| Ingrezza | 01/01/2024 | Valbenazine Tosylate | increased | 972.23 | 100 |
| Ingrezza | 01/01/2024 | Valbenazine Tosylate | increased | 972.23 | 100 |
| Inlyta | 01/01/2024 | Axitinib | increased | 972.23 | 100 |
| Inlyta | 01/01/2024 | Axitinib | increased | 972.23 | 100 |
| Inpen (For Humalog) | 01/01/2024 | Insulin Pen,Reusable,Bt Lispro | increased | 972.23 | 100 |
| Inpen (For Humalog) | 01/01/2024 | Insulin Pen,Reusable,Bt Lispro | increased | 972.23 | 100 |
| Inpen (For Novolog Or Fiasp) | 01/01/2024 | Insulin Pen,Reusable,Bt,Aspart | increased | 972.23 | 100 |
| Inpen (For Novolog Or Fiasp) | 01/01/2024 | Insulin Pen,Reusable,Bt,Aspart | increased | 972.23 | 100 |
| Inqovi | 01/01/2024 | Decitabine/Cedazuridine | increased | 972.23 | 100 |
| Inqovi | 01/01/2024 | Decitabine/Cedazuridine | increased | 972.23 | 100 |
| Inrebic | 01/01/2024 | Fedratinib Dihydrochloride | increased | 972.23 | 100 |
| Inrebic | 01/01/2024 | Fedratinib Dihydrochloride | increased | 972.23 | 100 |
| Invega Hafyera | 01/01/2024 | Paliperidone Palmitate | increased | 972.23 | 100 |
| Invega Hafyera | 01/01/2024 | Paliperidone Palmitate | increased | 972.23 | 100 |
| Invega Sustenna | 01/01/2024 | Paliperidone Palmitate | increased | 972.23 | 100 |
| Invega Sustenna | 01/01/2024 | Paliperidone Palmitate | increased | 972.23 | 100 |
| Invega Trinza | 01/01/2024 | Paliperidone Palmitate | increased | 972.23 | 100 |
| Invega Trinza | 01/01/2024 | Paliperidone Palmitate | increased | 972.23 | 100 |
| Inveltys | 01/01/2024 | Loteprednol Etabonate | increased | 972.23 | 100 |
| Inveltys | 01/01/2024 | Loteprednol Etabonate | increased | 972.23 | 100 |
| Iqirvo | 01/01/2024 | Elafibranor | increased | 972.23 | 100 |
| Iqirvo | 01/01/2024 | Elafibranor | increased | 972.23 | 100 |
| Iressa | 01/01/2024 | Gefitinib | increased | 972.23 | 100 |
| Iressa | 01/01/2024 | Gefitinib | increased | 972.23 | 100 |
| Isturisa | 01/01/2024 | Osilodrostat Phosphate | increased | 972.23 | 100 |
| Isturisa | 01/01/2024 | Osilodrostat Phosphate | increased | 972.23 | 100 |